Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes.

Bailey, C J

Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes. [electronic resource] - International journal of clinical practice Sep 2004 - 867-76 p. digital

Publication Type: Journal Article; Review

1368-5031

10.1111/j.1742-1241.2004.00318.x doi


Contraindications
Diabetes Mellitus, Type 2--drug therapy
Drug Combinations
Humans
Hypoglycemic Agents--pharmacokinetics
Insulin Resistance
Metformin--pharmacokinetics
Thiazoles--pharmacokinetics
Treatment Outcome